Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

2.

Expression of Concern: Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.

Ramana KV, Fadl AA, Tammali R, Reddy ABM, Chopra AK, Srivastava SK.

J Biol Chem. 2019 Feb 1;294(5):1633. doi: 10.1074/jbc.EC119.007462. No abstract available.

3.

Improved Therapeutic Window in BRCA-mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition.

Zhong H, Chen C, Tammali R, Breen S, Zhang J, Fazenbaker C, Kennedy M, Conway J, Higgs BW, Holoweckyj N, Raja R, Harper J, Pierce AJ, Herbst R, Tice DA.

Mol Cancer Ther. 2019 Jan;18(1):89-99. doi: 10.1158/1535-7163.MCT-18-0314. Epub 2018 Oct 23.

PMID:
30352801
4.

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer.

Cho S, Zammarchi F, Williams DG, Havenith CEG, Monks NR, Tyrer P, D'Hooge F, Fleming R, Vashisht K, Dimasi N, Bertelli F, Corbett S, Adams L, Reinert HW, Dissanayake S, Britten CE, King W, Dacosta K, Tammali R, Schifferli K, Strout P, Korade M 3rd, Masson Hinrichs MJ, Chivers S, Corey E, Liu H, Kim S, Bander NH, Howard PW, Hartley JA, Coats S, Tice DA, Herbst R, van Berkel PH.

Mol Cancer Ther. 2018 Oct;17(10):2176-2186. doi: 10.1158/1535-7163.MCT-17-0982. Epub 2018 Jul 31.

5.

Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice.

Saxena A, Tammali R, Ramana KV, Srivastava SK.

Curr Cancer Drug Targets. 2018;18(9):905-911. doi: 10.2174/1568009617666170808105633.

6.

Corrigendum to "Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders" [Chem. Biol. Interact. (2011) 330-338].

Srivastava SK, Yadav UC, Reddy AB, Mishra R, Saxena A, Tammali R, Shoeb M, Ansari NH, Bhatnagar A, Petrash MJ, Srivastava S, Ramana KV.

Chem Biol Interact. 2016 Jul 25;254:247. doi: 10.1016/j.cbi.2016.05.026. Epub 2016 May 27. No abstract available.

PMID:
27241459
7.

A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response.

Xiao Z, Carrasco RA, Schifferli K, Kinneer K, Tammali R, Chen H, Rothstein R, Wetzel L, Yang C, Chowdhury P, Tsui P, Steiner P, Jallal B, Herbst R, Hollingsworth RE, Tice DA.

Mol Cancer Ther. 2016 Apr;15(4):689-701. doi: 10.1158/1535-7163.MCT-15-0555. Epub 2016 Feb 15.

8.

A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways.

Rios-Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, Cheng L, Du Q, Schifferli K, Rothstein R, Leow CC, Heidbrink-Thompson J, Jin X, Gao C, Friedman J, Wilkinson B, Damschroder M, Pierce AJ, Hollingsworth RE, Tice DA, Michelotti EF.

Mol Cancer Ther. 2015 Jul;14(7):1637-49. doi: 10.1158/1535-7163.MCT-14-1040. Epub 2015 May 6.

9.

Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.

Saxena A, Shoeb M, Tammali R, Ramana KV, Srivastava SK.

Cancer Lett. 2014 Dec 1;355(1):141-7. doi: 10.1016/j.canlet.2014.09.006. Epub 2014 Sep 10.

10.

Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.

Saxena A, Tammali R, Ramana KV, Srivastava SK.

Antioxid Redox Signal. 2013 Apr 10;18(11):1249-62. doi: 10.1089/ars.2012.4643. Epub 2012 Oct 25.

11.

Inhibition of aldose reductase prevents colon cancer metastasis.

Tammali R, Reddy AB, Saxena A, Rychahou PG, Evers BM, Qiu S, Awasthi S, Ramana KV, Srivastava SK.

Carcinogenesis. 2011 Aug;32(8):1259-67. doi: 10.1093/carcin/bgr102. Epub 2011 Jun 3.

13.

Targeting aldose reductase for the treatment of cancer.

Tammali R, Srivastava SK, Ramana KV.

Curr Cancer Drug Targets. 2011 Jun;11(5):560-71. Review.

14.

Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.

Tammali R, Reddy AB, Srivastava SK, Ramana KV.

Angiogenesis. 2011 May;14(2):209-21. doi: 10.1007/s10456-011-9206-4. Epub 2011 Mar 16.

15.

Aldose reductase deficiency protects sugar-induced lens opacification in rats.

Reddy AB, Tammali R, Mishra R, Srivastava S, Srivastava SK, Ramana KV.

Chem Biol Interact. 2011 May 30;191(1-3):346-50. doi: 10.1016/j.cbi.2011.02.028. Epub 2011 Mar 3.

16.

Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

Srivastava SK, Yadav UC, Reddy AB, Saxena A, Tammali R, Shoeb M, Ansari NH, Bhatnagar A, Petrash MJ, Srivastava S, Ramana KV.

Chem Biol Interact. 2011 May 30;191(1-3):330-8. doi: 10.1016/j.cbi.2011.02.023. Epub 2011 Feb 24. Review.

17.

Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Ramana KV, Tammali R, Srivastava SK.

Mol Cancer Ther. 2010 Apr;9(4):813-24. doi: 10.1158/1535-7163.MCT-09-0795. Epub 2010 Mar 30.

18.

Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.

Tammali R, Saxena A, Srivastava SK, Ramana KV.

Endocrinology. 2010 May;151(5):2140-50. doi: 10.1210/en.2010-0160. Epub 2010 Mar 22.

19.

Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation.

Tammali R, Reddy AB, Ramana KV, Petrash JM, Srivastava SK.

Carcinogenesis. 2009 May;30(5):799-807. doi: 10.1093/carcin/bgn246. Epub 2008 Nov 20.

20.

Aldose reductase-regulated tumor necrosis factor-alpha production is essential for high glucose-induced vascular smooth muscle cell growth.

Ramana KV, Tammali R, Reddy AB, Bhatnagar A, Srivastava SK.

Endocrinology. 2007 Sep;148(9):4371-84. Epub 2007 Jun 21.

PMID:
17584970
21.

Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.

Ramana KV, Reddy AB, Tammali R, Srivastava SK.

Free Radic Biol Med. 2007 Apr 15;42(8):1290-302. Epub 2007 Jan 24.

22.

Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells.

Tammali R, Ramana KV, Srivastava SK.

Cancer Lett. 2007 Jul 18;252(2):299-306. Epub 2007 Feb 14.

23.

Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.

Pladzyk A, Reddy AB, Yadav UC, Tammali R, Ramana KV, Srivastava SK.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5395-403.

PMID:
17122129
24.

Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.

Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK.

Cancer Res. 2006 Oct 1;66(19):9705-13.

25.

Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.

Ramana KV, Fadl AA, Tammali R, Reddy AB, Chopra AK, Srivastava SK.

J Biol Chem. 2006 Nov 3;281(44):33019-29. Epub 2006 Sep 6.

26.

Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.

Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A.

Diabetes. 2006 Apr;55(4):901-10.

27.

Regulation of lens aldose reductase activity by nitric oxide.

Srivastava S, Tammali R, Chandra D, Greer DA, Ramana KV, Bhatnagar A, Srivastava SK.

Exp Eye Res. 2005 Dec;81(6):664-72. Epub 2005 Jun 20.

PMID:
15967436
28.

Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells.

Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK.

Diabetes. 2005 Mar;54(3):818-29.

30.

Supplemental Content

Loading ...
Support Center